Forte Biosciences Inc (FBRX) Stock Analysis
Sector: HEALTHCARE - BIOTECHNOLOGY
Exchange: NASDAQ
Key Metrics
- Price: $29.26
- Market Cap: $172.07M
- EPS: $-3.68
- 52-Week High: $35.62
- 52-Week Low: $4.90
Market Sentiment
Forte Biosciences Inc currently has a Bullish sentiment score of 0.24.
About Forte Biosciences Inc
Forte Biosciences Inc. (FBRX), a clinical-stage biopharmaceutical company headquartered in Torrance, California, specializes in the development of innovative therapeutics for skin diseases, particularly eczema and related conditions. Utilizing a proprietary platform grounded in advanced genetic and biological research, Forte aims to deliver targeted treatment solutions that promise enhanced patient outcomes. As the company progresses through clinical trials and regulatory considerations, it i...
GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Forte Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.
Frequently Asked Questions
Does FBRX pay dividends?
Forte Biosciences Inc (FBRX) does not currently pay a regular dividend.
What is FBRX's market cap?
Forte Biosciences Inc (FBRX) has a market capitalization of $172.07M with a current stock price of $29.26.